These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3496931

  • 1. Modulation of the response to B-cell growth factor (BCGF) of hairy cells from a patient under IFN-alpha therapy.
    Génot E, Mathiot C, Kolb JP.
    Blut; 1987 Jul; 55(1):65-7. PubMed ID: 3496931
    [No Abstract] [Full Text] [Related]

  • 2. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro.
    Paganelli KA, Evans SS, Han T, Ozer H.
    Blood; 1986 Apr; 67(4):937-42. PubMed ID: 2937473
    [Abstract] [Full Text] [Related]

  • 3. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
    Genot E, Sarfati M, Sigaux F, Petit-Koskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, Kolb JP.
    Blood; 1989 Nov 15; 74(7):2455-63. PubMed ID: 2529929
    [Abstract] [Full Text] [Related]

  • 4. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H, Brownstein BH, Gurfel D, Wu SH, Rosner MC, Golomb HM.
    Cancer Res; 1990 Jul 01; 50(13):4111-20. PubMed ID: 2354460
    [Abstract] [Full Text] [Related]

  • 5. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E, Valentine MA, Degos L, Sigaux F, Kolb JP.
    J Immunol; 1991 Feb 01; 146(3):870-8. PubMed ID: 1703183
    [Abstract] [Full Text] [Related]

  • 6. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
    Benjamin D, Bazar LS, Wallace B, Jacobson RJ.
    Cell Immunol; 1986 Dec 01; 103(2):394-408. PubMed ID: 3100061
    [Abstract] [Full Text] [Related]

  • 7. Growth factor-mediated tumor cell proliferation in hairy cell leukemia.
    Ford RJ, Yoshimura L, Morgan J, Quesada J, Montagna R, Maizel A.
    J Exp Med; 1985 Sep 01; 162(3):1093-8. PubMed ID: 2993470
    [Abstract] [Full Text] [Related]

  • 8. Expression of the B8.7 antigen on hairy cells and relation with the LMW-BCGF response.
    Génot E, Leprince C, Richard Y, Petit-Koskas E, Falcoff E, Galanaud P, Sigaux F, Kolb JP.
    Leukemia; 1989 May 01; 3(5):367-72. PubMed ID: 2785622
    [Abstract] [Full Text] [Related]

  • 9. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
    Genot E, Billard C, Sigaux F, Mathiot C, Degos L, Falcoff E, Kolb JP.
    Leukemia; 1987 Aug 01; 1(8):590-6. PubMed ID: 2444836
    [Abstract] [Full Text] [Related]

  • 10. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD, Cawley JC.
    Leukemia; 1988 Jun 01; 2(6):377-81. PubMed ID: 3374170
    [Abstract] [Full Text] [Related]

  • 11. The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells.
    Kehrl JH, Muraguchi A, Goldsmith PK, Fauci AS.
    Cell Immunol; 1985 Nov 01; 96(1):38-48. PubMed ID: 2424621
    [Abstract] [Full Text] [Related]

  • 12. Hairy-cells are not lysed by NK-cells.
    Sigaux F, Chapuis F, Castaigne S, Degos L, Flandrin G, Gluckman JC.
    Blut; 1987 May 01; 54(5):319-20. PubMed ID: 3567370
    [No Abstract] [Full Text] [Related]

  • 13. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT, Springgate CF, Piela TH, Choi YS.
    J Immunol; 1987 Apr 15; 138(8):2554-60. PubMed ID: 3031160
    [Abstract] [Full Text] [Related]

  • 14. Establishment of a human B cell line that proliferates in response to B cell growth factor.
    Abe H, Rossio JL, Ruscetti FW, Matsushima K, Oppenheim JJ.
    J Immunol Methods; 1986 Jun 10; 90(1):111-23. PubMed ID: 2423613
    [Abstract] [Full Text] [Related]

  • 15. [Hairy cell leukemia: therapeutic strategy].
    Flandrin G, Castaigne S.
    Presse Med; 1988 Apr 23; 17(15):714-5. PubMed ID: 2968546
    [No Abstract] [Full Text] [Related]

  • 16. The effect of cytokines, including IL-1, IL-4, and IL-6, in hairy cell proliferation/differentiation.
    Griffiths SD, Cawley JC.
    Leukemia; 1990 May 23; 4(5):337-40. PubMed ID: 2201827
    [Abstract] [Full Text] [Related]

  • 17. Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.
    Zinzani PL, Lauria F, Raspadori D, Buzzi M, Benfenati D, Bocchia M, Rondelli D, Tura S.
    Acta Haematol; 1991 May 23; 85(1):16-9. PubMed ID: 2011924
    [Abstract] [Full Text] [Related]

  • 18. The characterization of a human B cell line utilizable for the assay of B cell growth factors.
    Warrington RJ.
    J Immunol Methods; 1987 Jun 26; 100(1-2):117-22. PubMed ID: 3110293
    [Abstract] [Full Text] [Related]

  • 19. Production of B cell growth factor(s) by neoplastic B cells from hairy cell leukemia patients.
    Ford RJ, Kwok D, Quesada J, Sahasrabuddhe CG.
    Blood; 1986 Mar 26; 67(3):573-7. PubMed ID: 3484978
    [Abstract] [Full Text] [Related]

  • 20. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
    Defrance T, Aubry JP, Vanbervliet B, Banchereau J.
    J Immunol; 1986 Dec 15; 137(12):3861-7. PubMed ID: 3097134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.